Search Results Search Sort by RelevanceMost Recent Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673. Case and Commentary May 2019 Should Physicians Offer a Ventricular Assist Device to a Pediatric Oncology Patient With a Poor Prognosis? Angira Patel, MD, MPH, Anna Joong, MD, Efrat Lelkes, MD, and Jeffrey G. Gossett, MD When evaluating a 10-year-old with leukemia and chemo-induced heart failure for VAD placement, a team considers what to do. AMA J Ethics. 2019;21(5):E380-386. doi: 10.1001/amajethics.2019.380. Case and Commentary Aug 2022 When Is Iatrogenic Harm Negligent? Ramya Sampath All harm resulting from negligence is iatrogenic, but not all iatrogenic injury is negligent. AMA J Ethics. 2022;24(8):E735-739. doi: 10.1001/amajethics.2022.735. Case and Commentary Apr 2011 Rationing Treatments Based on Their Cost per QALY David A. Wong, MD, MSc, FRCS(C) In cost-effectiveness research, the cost of a medical intervention is reported as a dollar amount per quality-adjusted life year gained—the quality of health and the length of time over which the health state exists. Virtual Mentor. 2011;13(3):220-223. doi: 10.1001/virtualmentor.2011.13.4.ccas3-1104. Case and Commentary May 2007 Is Artificial Nutrition and Hydration Extraordinary Care? Kenneth Craig Micetich, MD An exploration of whether artificial nutrition and hydration is judged to be extraordinary care in Catholic health care ethics. Virtual Mentor. 2007;9(5):340-344. doi: 10.1001/virtualmentor.2007.9.5.ccas2-0705.
Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673.
Case and Commentary May 2019 Should Physicians Offer a Ventricular Assist Device to a Pediatric Oncology Patient With a Poor Prognosis? Angira Patel, MD, MPH, Anna Joong, MD, Efrat Lelkes, MD, and Jeffrey G. Gossett, MD When evaluating a 10-year-old with leukemia and chemo-induced heart failure for VAD placement, a team considers what to do. AMA J Ethics. 2019;21(5):E380-386. doi: 10.1001/amajethics.2019.380.
Case and Commentary Aug 2022 When Is Iatrogenic Harm Negligent? Ramya Sampath All harm resulting from negligence is iatrogenic, but not all iatrogenic injury is negligent. AMA J Ethics. 2022;24(8):E735-739. doi: 10.1001/amajethics.2022.735.
Case and Commentary Apr 2011 Rationing Treatments Based on Their Cost per QALY David A. Wong, MD, MSc, FRCS(C) In cost-effectiveness research, the cost of a medical intervention is reported as a dollar amount per quality-adjusted life year gained—the quality of health and the length of time over which the health state exists. Virtual Mentor. 2011;13(3):220-223. doi: 10.1001/virtualmentor.2011.13.4.ccas3-1104.
Case and Commentary May 2007 Is Artificial Nutrition and Hydration Extraordinary Care? Kenneth Craig Micetich, MD An exploration of whether artificial nutrition and hydration is judged to be extraordinary care in Catholic health care ethics. Virtual Mentor. 2007;9(5):340-344. doi: 10.1001/virtualmentor.2007.9.5.ccas2-0705.